Dr. Jean Chatellier
EVP and Managing Director

Please explain your role and responsibilities at Kybora.

I am primary responsible for growing KYBORA’s business in Europe. I also support deal origination and execution in other regions.

What are some of your most proud achievements or accomplishments? E.g., were you a recipient of any notable awards in the industry?

Prior to joining KYBORA, I was Chief Business Officer at Besins Healthcare, where, in three years, I completed 15 deals that are expected to generate close to $0.5B in revenues over the next five years. Before Besins Healthcare, I was Vice President Business Development at Avadel Pharmaceuticals where I contributed, starting with the acquisition of Eclat Pharmaceuticals, to the transformation of a standalone drug delivery fee for service business into a profitable specialty pharma. Before that, I was Director of Business Development at Micromet (now Amgen) where I participated to strategic partnerships (altogether for over $1B value) with Bayer Healthcare Pharmaceuticals, Boehringer Ingelheim, Lonza and Sanofi. I also worked for Crucell (now Johnson & Johnson) as business developer and, various Venture Capital firms as CEO and liquidator. I was the founding CEO of Avidis (now Osivax), a Medical Research Council spin-off set-up with Sirs Alan R. Fersht and John E. Walker (Nobel Prize in chemistry 1997).

Do you have any relevant or notable experience that you would like to highlight? E.g., roles at previous companies, companies you’ve founded, boards you advise, etc.

I have 23+ years of experience across a broad range of functions (incl. BoD, CEO and CBO) and varied Pharmaceutical/Biotechnology/MedTech industry segments and marketplaces (USA, EU, CIS-CEE (incl. RU), LATAM, ASPAC (incl. CN, IN & JP) and MENA-GCC). I am skilled in the identification, assessment (incl. leading cross-functional diligence team, conducting market research and strategic positioning and, performing NPV/rNPV analysis), negotiation (structure and terms/conditions), maintenance and expansion of various partnerships (M&A (buy & sell), licensing (in & out), co-promotion, co-development, R&D partnership, manufacturing/supply, and funds raising) across multiple drugs (small molecules & biologics), therapeutic areas and technology platforms, in high level business/scientific and multi-national environments. I ahve well-developed project management and leadership qualities to successfully navigate complex decision-making structure for closing deals and implementing and expanding businesses (including start-ups).

Please share your educational background – degree, university, etc.

I have a PhD in Biochemistry and Molecular Biology (Strasbourg, France) and I performed post-doctoral research with Sirs Allan R. Fersht and Greg P. Winter (Nobel Prize in chemistry 2018) at the Center for Protein Engineering of the MRC (Cambridge, UK).

Personalize your information. Please share any relevant interests or passions that may appeal to potential clients.


If you have any social media profiles or personal websites that are professional and industry-related that can be linked from your section, please include them here. (LinkedIn, Twitter, etc.).


+33 609 102 105
Meet the whole team